<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>201(4)</volume><submitter>Paterson LC</submitter><funding>Atomic Energy of Canada Limited's Federal Nuclear Science &amp; Technology Work Plan</funding><pubmed_abstract>The reported relative biological effectiveness (RBE) for thermal neutrons has a large range (5-51, for cytogenetic endpoints), which can confound radiation protection decision-making. To determine whether thermal neutron spectra can influence RBE, the RBE of reactor-derived thermal neutrons of average energy 31 meV was evaluated in human peripheral blood lymphocytes using two classical DNA double-strand break endpoints: the dicentric chromosome assay (DCA) and the cytokinesis-block micronucleus assay. Dose-response curves for 41 to 408 mGy revealed a preference for linear regression. Maximum RBE (RBEM) values of 6.7 ± 0.9 and 4.4 ± 0.7 were calculated for the DCA and the micronucleus assay, respectively. These 31 meV RBEM values were significantly lower than our prior results for 64 meV th</pubmed_abstract><journal>Radiation protection dosimetry</journal><pagination>297-313</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11926985</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Relative biological effectiveness of 31 meV thermal neutrons in peripheral blood lymphocytes.</pubmed_title><pmcid>PMC11926985</pmcid><pubmed_authors>Boyer C</pubmed_authors><pubmed_authors>Paterson LC</pubmed_authors><pubmed_authors>Ali F</pubmed_authors><pubmed_authors>Naseri M</pubmed_authors><pubmed_authors>Costello C</pubmed_authors><pubmed_authors>Perez Loureiro D</pubmed_authors><pubmed_authors>Ybarra N</pubmed_authors><pubmed_authors>Stuart M</pubmed_authors><pubmed_authors>Festarini A</pubmed_authors><pubmed_authors>Rogge R</pubmed_authors><pubmed_authors>Kildea J</pubmed_authors><pubmed_authors>Richardson RB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Relative biological effectiveness of 31 meV thermal neutrons in peripheral blood lymphocytes.</name><description>The reported relative biological effectiveness (RBE) for thermal neutrons has a large range (5-51, for cytogenetic endpoints), which can confound radiation protection decision-making. To determine whether thermal neutron spectra can influence RBE, the RBE of reactor-derived thermal neutrons of average energy 31 meV was evaluated in human peripheral blood lymphocytes using two classical DNA double-strand break endpoints: the dicentric chromosome assay (DCA) and the cytokinesis-block micronucleus assay. Dose-response curves for 41 to 408 mGy revealed a preference for linear regression. Maximum RBE (RBEM) values of 6.7 ± 0.9 and 4.4 ± 0.7 were calculated for the DCA and the micronucleus assay, respectively. These 31 meV RBEM values were significantly lower than our prior results for 64 meV th</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-05T12:38:43.397Z</modification><creation>2025-04-05T12:38:43.397Z</creation></dates><accession>S-EPMC11926985</accession><cross_references><pubmed>40062825</pubmed><doi>10.1093/rpd/ncae231</doi></cross_references></HashMap>